At the end of the latest market close, Tonix Pharmaceuticals Holding Corp. (TNXP) was valued at $1.30. In that particular session, Stock kicked-off at the price of $1.301 while reaching the peak value of $1.34 and lowest value recorded on the day was $1.28. The stock current value is $1.33.
Recently in News on June 10, 2021, Tonix Pharmaceuticals to Participate in BIO Digital Conference. Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the BIO Digital Conference being held June 10-11 and 14-18, 2021. You can read further details here
Tonix Pharmaceuticals Holding Corp. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1200 on 02/11/21, with the lowest value was $0.6500 for the same time period, recorded on 01/04/21.
Tonix Pharmaceuticals Holding Corp. (TNXP) full year performance was 94.90%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Tonix Pharmaceuticals Holding Corp. shares are logging -45.93% during the 52-week period from high price, and 160.78% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.51 and $2.46.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5376889 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Tonix Pharmaceuticals Holding Corp. (TNXP) recorded performance in the market was 97.04%, having the revenues showcasing 4.72% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 427.99M, as it employees total of 26 workers.
The Analysts eye on Tonix Pharmaceuticals Holding Corp. (TNXP)
During the last month, 0 analysts gave the Tonix Pharmaceuticals Holding Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2032, with a change in the price was noted +0.42. In a similar fashion, Tonix Pharmaceuticals Holding Corp. posted a movement of +45.85% for the period of last 100 days, recording 24,048,516 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TNXP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Tonix Pharmaceuticals Holding Corp. (TNXP)
Raw Stochastic average of Tonix Pharmaceuticals Holding Corp. in the period of last 50 days is set at 81.63%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 79.89%. In the last 20 days, the company’s Stochastic %K was 76.09% and its Stochastic %D was recorded 80.16%.
Considering, the past performance of Tonix Pharmaceuticals Holding Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 97.04%. Additionally, trading for the stock in the period of the last six months notably improved by 106.20%, alongside a boost of 94.90% for the period of the last 12 months. The shares increased approximately by 1.53% in the 7-day charts and went down by 27.88% in the period of the last 30 days. Common stock shares were driven by 4.72% during last recorded quarter.